You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: ThermoDynamic Films LLC Topic: CBD171001
This Phase-II SBIR proposal directly addresses the need to improve the size, weight and power, SWaP, of optical cryocoolers. In particular, the proposers will work toward increasing the efficiency of optical cryocoolers by incorporating cooling materials that require less input laser power to achieve a given heat lift. The new cooling materials will be high-purity crystals doped with active rare-e ...SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: Zymeron Corporation Topic: CBD181004
Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: SensoDX II, LLC Topic: A16AT008
The synthetic opioids fentanyl and carfentanil pose an imminent national security threat, given the ease with which they can be obtained, their low lethal doses, and their potential for weaponized use. The purpose of this agreement is to adapt SensoDx’s high-performance miniaturized diagnostics platform based on a programmable bio-nano-chip, with embedded artificial intelligence, to enable U.S. ...SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense